Pancreatic trypsin activates human promatrix metalloproteinase-2

Journal of Molecular Biology

Volumn 350, Issue 4, 2005, Pages 682-698

  Lindstad, Rune I ^a   Sylte, Ingebrigt ^a   Mikalsen, Svein Ole ^b   Seglen, Per O ^b   Berg, Eli ^a   Winberg, Jan Olof ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

GelatinaseA; MT MMP; Promatrix metalloproteinase 2; TIMP; Trypsin

Indexed keywords

CALCIUM ION; ENZYME INHIBITOR; ENZYME PRECURSOR; GELATINASE A; LYSINE; MATRIX METALLOPROTEINASE 14; PANCREAS ENZYME; PHENYLALANINE; POLIDOCANOL; TRYPSIN; TRYPTOPHAN; TYROSINE;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; ENVIRONMENTAL FACTOR; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; IN VIVO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROCESSING; STEADY STATE; TEMPERATURE;

EID: 20544478569     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2005.05.018     Document Type: Article

References (83)

1. H. Birkedal-Hansen Role of matrix metalloproteinases in human periodontal diseases J. Periodontol. 64 1993 474 484
2. G. Murphy, and T. Crabbe Gelatinases A and B Methods Enzymol. 248 1995 470 484
3. H. Nagase Activation mechanisms of matrix metalloproteinases Biol. Chem. 378 1997 151 160
4. Y. Wang, A.R. Johnson, Q.Z. Ye, and R.D. Dyer Catalytic activities and substrate specificity of the human membrane type 4 matrix metalloproteinase catalytic domain J. Biol. Chem. 274 1999 33043 33049
5. G. Velasco, S. Cal, A. Merlos-Suarez, A.A. Ferrando, S. Alvarez, and A. Nakano Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors Cancer Res. 60 2000 877 882
6. W. Bode, C. Fernandez-Catalan, H. Tschesche, F. Grams, H. Nagase, and K. Maskos Structural properties of matrix metalloproteinases Cell. Mol. Life Sci. 55 1999 639 652
7. W. Bode Structural basis of matrix metalloproteinase function Biochem. Soc. Symp. 2003 1 14
8. W. Bode, and K. Maskos Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases Biol. Chem. 384 2003 863 872
9. R. Visse, and H. Nagase Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry Circ. Res. 92 2003 827 839
10. E. Morgunova, A. Tuuttila, U. Bergmann, M. Isupov, Y. Lindqvist, G. Schneider, and K. Tryggvason Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed Science 284 1999 1667 1670
11. E. Morgunova, A. Tuuttila, U. Bergmann, and K. Tryggvason Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2 Proc. Natl Acad. Sci. USA 99 2002 7414 7419
12. U. Gohlke, F.X. Gomis-Ruth, T. Crabbe, G. Murphy, A.J. Docherty, and W. Bode The C-terminal (haemopexin-like) domain structure of human gelatinase A (MMP2): structural implications for its function FEBS Letters 378 1996 126 130
13. F.X. Gomis-Ruth, U. Gohlke, M. Betz, V. Knauper, G. Murphy, C. Lopez-Otin, and W. Bode The helping hand of collagenase-3 (MMP-13): 2.7 Å crystal structure of its C-terminal haemopexin-like domain J. Mol. Biol. 264 1996 556 566
14. K. Brew, D. Dinakarpandian, and H. Nagase Tissue inhibitors of metalloproteinases: evolution, structure and function Biochim. Biophys. Acta. 1477 2000 267 283
15. C.C. Lynch, and L.M. Matrisian Matrix metalloproteinases in tumor-host cell communication Differentiation 70 2002 561 573
16. L.J. McCawley, and L.M. Matrisian Matrix metalloproteinases: they're not just for matrix anymore! Curr. Opin. Cell Biol. 13 2001 534 540
17. J.F. Woessner Jr Matrix metalloproteinases and their inhibitors in connective tissue remodeling FASEB J. 5 1991 2145 2154
18. H. Nagase, and J.F. Woessner Jr Matrix metalloproteinases J. Biol. Chem. 274 1999 21491 21494
19. C.M. Dollery, J.R. McEwan, and A.M. Henney Matrix metalloproteinases and cardiovascular disease Circ. Res. 77 1995 863 868
20. L.A. Rudolph-Owen, R. Chan, W.J. Muller, and L.M. Matrisian The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis Cancer Res. 58 1998 5500 5506
21. T. Sorsa, L. Tjaderhane, and T. Salo Matrix metalloproteinases (MMPs) in oral diseases Oral Dis. 10 2004 311 318
22. X.H. Wehrens, and P.A. Doevendans Cardiac rupture complicating myocardial infarction Int. J. Cardiol. 95 2004 285 292
23. C. Avolio, F. Giuliani, G.M. Liuzzi, M. Ruggieri, D. Paolicelli, and P. Riccio Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta Brain Res. Bull. 61 2003 357 364
24. J.R. MacDougall, and L.M. Matrisian Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis Cancer Metastasis Rev. 14 1995 351 362
25. S. Manes, M. Llorente, R.A. Lacalle, C. Gomez-Mouton, L. Kremer, E. Mira, and A.C. Martinez The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells J. Biol. Chem. 274 1999 6935 6945
26. P. Vihinen, and V.M. Kahari Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets Int. J. Cancer 99 2002 157 166
27. W.G. Stetler-Stevenson Type IV collagenases in tumor invasion and metastasis Cancer Metastasis Rev. 9 1990 289 303
28. V. Shah, S. Kumar, and K.A. Zirvi Metastasis of human colon tumor cells in vivo: correlation with the overexpression of plasminogen activators and 72 kDa gelatinase In Vivo 8 1994 321 326
29. T. Terada, Y. Okada, and Y. Nakanuma Expression of matrix proteinases during human intrahepatic bile duct development. A possible role in biliary cell migration Am. J. Pathol. 147 1995 1207 1213
30. Y. Okada, T. Morodomi, J.J. Enghild, K. Suzuki, A. Yasui, and I. Nakanishi Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties Eur. J. Biochem. 194 1990 721 730
31. T. Crabbe, J.P. O'Connell, B.J. Smith, and A.J. Docherty Reciprocated matrix metalloproteinase activation: a process performed by interstitial collagenase and progelatinase A Biochemistry 33 1994 14419 14425
32. T. Crabbe, B. Smith, J. O'Connell, and A. Docherty Human progelatinase A can be activated by matrilysin FEBS Letters 345 1994 14 16
33. A.Y. Strongin, I. Collier, G. Bannikov, B.L. Marmer, G.A. Grant, and G.I. Goldberg Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease J. Biol. Chem. 270 1995 5331 5338
34. P. Kurschat, P. Zigrino, R. Nischt, K. Breitkopf, P. Steurer, and C.E. Klein Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines J. Biol. Chem. 274 1999 21056 21062
35. M. Seiki Membrane-type matrix metalloproteinases APMIS 107 1999 137 143
36. E. Pezzato, M. Dona, L. Sartor, I. Dell'Aica, R. Benelli, A. Albini, and S. Garbisa Proteinase-3 directly activates MMP-2 and degrades gelatin and Matrigel; differential inhibition by (-)epigallocatechin-3-gallate J. Leukoc. Biol. 74 2003 88 94
37. M. Nguyen, J. Arkell, and C.J. Jackson Activated protein C directly activates human endothelial gelatinase A J. Biol. Chem. 275 2000 9095 9098
38. M. Takeda, K. Imada, T. Sato, and A. Ito Activation of human progelatinase A/promatrix metalloproteinase 2 by Escherichia coli-derived serine proteinase Biochem. Biophys. Res. Commun. 268 2000 128 132
39. E. Tchougounova, A. Lundequist, I. Fajardo, J.O. Winberg, M. Abrink, and G. Pejler A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and -2 J. Biol. Chem. 280 2005 9291 9296
40. Y. Okada, and I. Nakanishi Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ("gelatinase") by human neutrophil elastase and cathepsin G FEBS Letters 249 1989 353 356
41. D.S. Hipps, R.M. Hembry, A.J. Docherty, J.J. Reynolds, and G. Murphy Purification and characterization of human 72-kDa gelatinase (type IV collagenase). Use of immunolocalisation to demonstrate the non-coordinate regulation of the 72-kDa and 95-kDa gelatinases by human fibroblasts Biol. Chem. Hoppe Seyler 372 1991 287 296
42. T. Sorsa, T. Salo, E. Koivunen, J. Tyynela, Y.T. Konttinen, and U. Bergmann Activation of type IV procollagenases by human tumor-associated trypsin- 2 J. Biol. Chem. 272 1997 21067 21074
43. G. Sanchez, J.L. Seltzer, A.Z. Eisen, P. Stapler, and E.A. Bauer Generalized dominant epidermolysis bullosa simplex: decreased activity of a gelatinolytic protease in cultured fibroblasts as a phenotypic marker J. Invest. Dermatol. 81 1983 576 579
44. V. Lefebvre, C. Peeters-Joris, and G. Vaes Production of gelatin-degrading matrix metalloproteinases ("type IV collagenases") and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor alpha Biochim. Biophys. Acta 1094 1991 8 18
45. J.O. Winberg, and T. Gedde-Dahl Gelatinase expression in generalized epidermolysis bullosa simplex fibroblasts J. Invest. Dermatol. 87 1986 326 329
46. J.O. Winberg, and T. Gedde-Dahl Jr Epidermolysis bullosa simplex: expression of gelatinase activity in cultured human skin fibroblasts Biochem. Genet. 30 1992 401 420
47. O.V. Krokhin, W. Ens, and K.G. Standing Characterizing degradation products of peptides containing N-terminal Cys residues by (off-line high-performance liquid chromatography)/matrix-assisted laser desorption/ionization quadrupole time-of-flight measurements Rapid Commun. Mass Spectrom. 17 2003 2528 2534
48. W.G. Stetler-Stevenson, H.C. Krutzsch, M.P. Wacher, I.M. Margulies, and L.A. Liotta The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation J. Biol. Chem. 264 1989 1353 1356
49. I. Pucci-Minafra, S. Minafra, G. La Rocca, M. Barranca, S. Fontana, G. Alaimo, and Y. Okada Zymographic analysis of circulating and tissue forms of colon carcinoma gelatinase A (MMP-2) and B (MMP-9) separated by mono- and two-dimensional electrophoresis Matrix Biol. 20 2001 419 427
50. P.J. Henderson A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors Biochem. J. 127 1972 321 333
51. U. Bergmann, A. Tuuttila, W.G. Stetler-Stevenson, and K. Tryggvason Autolytic activation of recombinant human 72 kilodalton type IV collagenase Biochemistry 34 1995 2819 2825
52. H. Emonard, and W. Hornebeck Binding of 92 kDa and 72 kDa progelatinases to insoluble elastin modulates their proteolytic activation Biol. Chem. 378 1997 265 271
53. 2+ and other ions as extracellular (first) messengers Physiol. Rev. 71 1991 371 411
54. C.M. Overall, A.E. King, D.K. Sam, A.D. Ong, T.T. Lau, and U.M. Wallon Identification of the tissue inhibitor of metalloproteinases-2 (TIMP-2) binding site on the hemopexin carboxyl domain of human gelatinase A by site-directed mutagenesis. The hierarchical role in binding TIMP-2 of the unique cationic clusters of hemopexin modules III and IV J. Biol. Chem. 274 1999 4421 4429
55. J. Benach, J.O. Winberg, J.S. Svendsen, S. Atrian, R. Gonzalez-Duarte, and R. Ladenstein Drosophila alcohol dehydrogenase: acetate-enzyme interactions and novel insights into the effects of electrostatics on catalysis J. Mol. Biol. 345 2005 579 598
56. S.J. Atkinson, T. Crabbe, S. Cowell, R.V. Ward, M.J. Butler, and H. Sato Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes J. Biol. Chem. 270 1995 30479 30485
57. V.S. Ossovskaya, and N.W. Bunnett Protease-activated receptors: contribution to physiology and disease Physiol. Rev. 84 2004 579 621
58. J.F. Tarlton, C.V. Whiting, D. Tunmore, S. Bregenholt, J. Reimann, M.H. Claesson, and P.W. Bland The role of up-regulated serine proteases and matrix metalloproteinases in the pathogenesis of a murine model of colitis Am. J. Pathol. 157 2000 1927 1935
59. A. Paju, T. Sorsa, T. Tervahartiala, E. Koivunen, C. Haglund, and A. Leminen The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation Br. J. Cancer 84 2001 1363 1371
60. T. Koshiba, R. Hosotani, M. Wada, K. Fujimoto, J.U. Lee, and R. Doi Detection of matrix metalloproteinase activity in human pancreatic cancer Surg. Today 27 1997 302 304
61. V. Ellenrieder, B. Alber, U. Lacher, S.F. Hendler, A. Menke, and W. Boeck Role of MT-MMPs and MMP-2 in pancreatic cancer progression Int. J. Cancer 85 2000 14 20
62. M.R. Emmert-Buck, M.J. Roth, Z. Zhuang, E. Campo, J. Rozhin, and B.F. Sloane Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples Am. J. Pathol. 145 1994 1285 1290
63. E. Koivunen, O. Itkonen, H. Halila, and U.H. Stenman Cyst fluid of ovarian cancer patients contains high concentrations of trypsinogen-2 Cancer Res. 50 1990 2375 2378
64. N. Koshikawa, H. Yasumitsu, Y. Nagashima, M. Umeda, and K. Miyazaki Identification of one- and two-chain forms of trypsinogen 1 produced by a human gastric adenocarcinoma cell line Biochem. J. 303 1994 187 190
65. T. Koshiba, R. Hosotani, M. Wada, Y. Miyamoto, K. Fujimoto, and J.U. Lee Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma Cancer 82 1998 642 650
66. R.C. Tsang, and H. Marder Bone disease L.A. Kaplan A.J. Pesce Clinical Chemistry: Theory, Analysis, and Correlation 2nd edit. 1989 C.V. Mosby Company St. Louis, MO 373 389
67. G. Deby-Dupont, M. Reynaert, P. Damas, M. Lamy, and P. Franchimont Biochemical justification of drainage of the thoracic duct in acute necrotic-hemorrhagic pancreatitis Acta. Gastroenterol. Belg. 51 1988 31 40
68. M. Lempinen, U.H. Stenman, P. Puolakkainen, A. Hietaranta, R. Haapiainen, and E. Kemppainen Sequential changes in pancreatic markers in acute pancreatitis Scand. J. Gastroenterol. 38 2003 666 675
69. B.E. Muhs, S. Patel, H. Yee, S. Marcus, and P. Shamamian Increased matrix metalloproteinase expression and activation following experimental acute pancreatitis J. Surg. Res. 101 2001 21 28
70. A. Munoz, and D.A. Katerndahl Diagnosis and management of acute pancreatitis Am. Fam. Physician 62 2000 164 174
71. D.M. Goldberg Proteases in the evaluation of pancreatic function and pancreatic disease Clin. Chim. Acta 291 2000 201 221
72. H. Rinderknecht, and M.C. Geokas On the physiological role of 2 -macroglobulin Biochim. Biophys. Acta 295 1973 233 244
73. J.G. Bieth, M. Tourbez-Perrin, and F. Pochon Inhibition of alpha 2-macroglobulin-bound trypsin by soybean trypsin inhibitor J. Biol. Chem. 256 1981 7954 7957
74. B. Mathisen, R.I. Lindstad, J. Hansen, S.A. El-Gewely, G.M. Maelandsmo, and E. Hovig S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells Clin. Expt. Metastasis 20 2003 701 711
75. T. Loennechen, B. Mathisen, J. Hansen, R.I. Lindstad, S.A. El-Gewely, and K. Andersen Colchicine induces membrane-associated activation of matrix metalloproteinase-2 in osteosarcoma cells in an S100A4-independent manner Biochem. Pharmacol. 66 2003 2341 2353
76. C.G. Knight, F. Willenbrock, and G. Murphy A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases FEBS Letters 296 1992 263 266
77. J.O. Winberg, S.O. Kolset, E. Berg, and L. Uhlin-Hansen Macrophages secrete matrix metalloproteinase 9 covalently linked to the core protein of chondroitin sulphate proteoglycans J. Mol. Biol. 304 2000 669 680
78. J.O. Winberg, E. Berg, S.O. Kolset, and L. Uhlin-Hansen Calcium-induced activation and truncation of promatrix metalloproteinase-9 linked to the core protein of chondroitin sulfate proteoglycans Eur. J. Biochem. 270 2003 3996 4007
79. J.O. Winberg, D.R. Thatcher, and J.S. McKinley-McKee Drosophila melanogaster alcohol dehydrogenase: an electrophoretic study of the AdhS, AdhF, and AdhUF alleloenzymes Biochem. Genet. 21 1983 63 80
80. R.L. Beardsley, and J.P. Reilly Optimization of guanidination procedures for MALDI mass mapping Anal. Chem. 74 2002 1884 1890
81. R.A. Abagyan, M.M. Totrov, and D.N. Kuznetsov ICM-a new method for protein modelling and design. Application to docking and structure prediction from the distroed native conformation J. Comput. Chem. 15 1994 488 506
82. R. Abagyan, and M. Totrov Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins J. Mol. Biol. 235 1994 983 1002
83. F.X. Gomis-Ruth, K. Maskos, M. Betz, A. Bergner, R. Huber, and K. Suzuki Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1 Nature 389 1997 77 81